Biomarker-guided selection of intravesical therapy in high-risk non-muscle invasive bladder cancer: A contemporary review. Ito W, Tachibana I. Ther Adv Urol 2026;18:17562872261485770.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ito W, Tachibana I. Biomarker-guided selection of intravesical therapy in high-risk non-muscle invasive bladder cancer: A contemporary review. Ther Adv Urol 2026;18:17562872261485770.
PMID: 42694519